HighTower Advisors LLC lessened its position in Aflac Incorporated (NYSE:AFL – Free Report) by 25.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 655,709 shares of the financial services provider’s stock after selling 229,026 shares during the period. HighTower Advisors LLC’s holdings in Aflac were worth $73,295,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also modified their holdings of the business. Groupe la Francaise bought a new stake in Aflac in the 1st quarter worth about $25,000. Archer Investment Corp purchased a new position in shares of Aflac during the second quarter valued at approximately $26,000. Edmond DE Rothschild Holding S.A. purchased a new position in shares of Aflac during the second quarter valued at approximately $27,000. Markowski Investments bought a new position in Aflac during the second quarter valued at approximately $29,000. Finally, Washington Trust Advisors Inc. bought a new position in Aflac during the second quarter valued at approximately $29,000. Institutional investors own 67.44% of the company’s stock.
Aflac Stock Down 1.9%
AFL stock opened at $125.24 on Thursday. The business’s 50-day moving average price is $119.14 and its 200-day moving average price is $116.91. The stock has a market cap of $61.94 billion, a P/E ratio of 17.02, a PEG ratio of 1.78 and a beta of 0.55. The company has a quick ratio of 0.11, a current ratio of 0.11 and a debt-to-equity ratio of 0.30. Aflac Incorporated has a twelve month low of $105.76 and a twelve month high of $131.18.
Aflac Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 1st. Shareholders of record on Wednesday, February 17th will be issued a dividend of $0.64 per share. This is a boost from Aflac’s previous quarterly dividend of $0.61. This represents a $2.56 dividend on an annualized basis and a yield of 2.0%. The ex-dividend date of this dividend is Wednesday, February 17th. Aflac’s payout ratio is 35.57%.
Analysts Set New Price Targets
AFL has been the topic of several research reports. Wolfe Research began coverage on shares of Aflac in a report on Wednesday, August 19th. They issued an “underperform” rating and a $103.00 target price on the stock. Keefe, Bruyette & Woods decreased their target price on shares of Aflac from $125.00 to $120.00 and set a “market perform” rating for the company in a research note on Friday, October 9th. Jefferies Financial Group raised their price target on Aflac from $108.00 to $112.00 and gave the stock a “hold” rating in a research note on Monday, August 10th. Barclays reissued an “underweight” rating and issued a $101.00 target price (up from $99.00) on shares of Aflac in a report on Wednesday, October 7th. Finally, UBS Group reissued a “neutral” rating and issued a $125.00 target price (up from $124.00) on shares of Aflac in a research report on Tuesday, October 6th. Four research analysts have rated the stock with a Buy rating, eight have given a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $118.73.
Get Our Latest Analysis on AFL
Insider Transactions at Aflac
In other news, Director Joseph Moskowitz sold 600 shares of the company’s stock in a transaction dated Monday, November 9th. The stock was sold at an average price of $124.99, for a total value of $74,994.00. Following the completion of the transaction, the director owned 32,119 shares of the company’s stock, valued at $4,014,553.81. This represents a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, major shareholder Post Holdings Co. Ltd. Japan sold 19,530 shares of the company’s stock in a transaction that occurred on Monday, November 16th. The stock was sold at an average price of $127.95, for a total value of $2,498,863.50. Following the completion of the transaction, the insider owned 50,058,899 shares of the company’s stock, valued at $6,405,036,127.05. The trade was a 0.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 695,092 shares of company stock worth $81,555,154. Insiders own 0.80% of the company’s stock.
About Aflac
Aflac Incorporated is an insurance company that provides supplemental health and life insurance to individuals and businesses. Its products are designed to help customers manage expenses that may not be covered by major medical insurance, including costs associated with accidents, cancer, critical illness and hospital stays. The company operates primarily in the United States and Japan. In the U.S., Aflac offers workplace benefits such as accident, disability, dental, vision and life insurance. In Japan, it provides products including cancer, medical and life insurance.
Further Reading
- Five stocks we like better than Aflac
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.
